Replies to post #392094 on Amarin Corp Plc (AMRN)

[couldbebetter]

Thanks Raf, Much appreciated as always!

[dukesking]

Raf. Thanks for the numbers. AMRN’s hanging in there while DRL is eating everyone’s lunch.

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[Megc]

Thank you Raf!

[Invest83838]

Fake Vascepa now at 2/3rds of Vascepa

but of course no infringement is occurring

[ilovetech]

Didn't Reddy complain that Amrn interfered with Reddy's supply readiiness, while we're seeing that they're share is higher than Hikma?

ILT

[rafunrafun]

Scripts for week ending October 28, 2022

Drug Industry TRx: +0.0% w/w; +8.4% y/y

Vascepa
TRx 62,654; -0.9% (-549) w/w; -19.3% y/y
NRx 28,394; -2.0% (-582) w/w; -18.5% y/y
Ref 34,260; +0.1% (+33) w/w; -19.9% y/y

Fake Vascepa
TRx 40,911; -2.4% (-1,007) w/w; As % of total V: 39.5%
NRx 19,490; -3.5% (-705) w/w; As % of total V: 40.7%
Ref 21,421; -1.4% (-302) w/w; As % of total V: 38.5%

Fake Vascepa by Manufacturer
Hikma - TRx 14,157; -234 w/w; Generic share 34.6%; Total V share 13.7%
Reddy - TRx 19,014; -709 w/w; Generic share 46.5%; Total V share 18.4%
Apotex - TRx 7,588; -16 w/w; Generic share 18.5%; Total V share 7.3%
Teva - TRx 152; -49 w/w; Generic share 0.4%; Total V share 0.1%

Vascepa + Fake Vascepa
TRx 103,565; -1.5% (-1,556) w/w; +4.9% y/y
NRx 47,884; -2.6% (-1,287) w/w; +2.0% y/y
Ref 55,681; -0.5% (-269) w/w; +7.5% y/y

Lovaza (Fake & Brand)
TRx 63,164; -2.5% (-1,588) w/w; +1.1% y/y
NRx 30,431; -3.2% (-1,012) w/w; -0.1% y/y
Ref 32,733; -4.8% (-586) w/w; +2.2% y/y